Erratum for: Weight reduction and maintenance with IQP-PV-101: A 12-week randomized controlled study with a 24-week open label period
نویسندگان
چکیده
منابع مشابه
Weight reduction and maintenance with IQP-PV-101: a 12-week randomized controlled study with a 24-week open label period.
OBJECTIVE The safety and efficacy of IQP-PV-101, a proprietary extract of Phaseolus vulgaris, on weight management in two phases was evaluated here. The weight loss (WL) phase was conducted over 12 weeks and the weight maintenance (WM) phase took 24 weeks. METHODS In the double-blind WL phase, subjects were randomized to receive either IQP-PV-101 or placebo. All subjects adhered to a mildly h...
متن کاملWeight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study
BACKGROUND Litramine (IQP-G-002AS) was shown to be effective and safe for weight loss in overweight and obese subjects. However, long-term effectiveness on maintenance of body weight loss has yet to be ascertained. OBJECTIVE To assess effect of Litramine on maintenance of body weight loss. METHODS A double-blind, randomised, placebo-controlled trial on overweight and obese patients was cond...
متن کاملSix-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study.
OBJECTIVE Little is known about the optimal duration of antibiotic therapy for diabetic foot osteomyelitis (DFO). This study sought to compare the effectiveness of 6 versus 12 weeks of antibiotic therapy in patients with DFO treated nonsurgically (i.e., antibiotics alone). RESEARCH DESIGN AND METHODS This was a prospective randomized trial comparing 6- versus 12-week duration of antibiotic tr...
متن کاملA 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...
متن کاملA 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obesity
سال: 2014
ISSN: 1930-7381
DOI: 10.1002/oby.20872